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Abstract 
The key problem in treating cocaine addiction is the maintenance of a drug-free state since negative 
emotional symptoms during abstinence often trigger relapse. The mechanisms underpinning the 
emotional dysregulation during abstinence are currently not well-understood. There is evidence 
suggesting a role of the neuropeptide oxytocin in the modulation of drug addiction processes. 
However, its involvement during long-term abstinence from cocaine use remains unclear. In this 
study, we aimed to behaviourally characterize a mouse model of long-term cocaine withdrawal and 
assess the effect of chronic cocaine administration and long-term cocaine abstinence on the central 
oxytocinergic system and the Hypothalamic-Pituitary-Adrenal-axis. Fourteen-day escalating-dose 
cocaine administration (3 x 15-30 mg/kg/day) and 14-day withdrawal increased plasma corticosterone 
levels and oxytocin receptor (OTR) binding in piriform cortex, lateral septum and amygdala. A 
specific cocaine withdrawal-induced increase in OTR binding was observed in the medial septum. 
These biochemical alterations occurred concomitantly with the emergence of memory impairment, 
contextual psychomotor sensitization and an anhedonic and anxiogenic phenotype during withdrawal. 
Our study established a clear relationship between cocaine abstinence and emotional impairment in a 
novel translationally-relevant model of cocaine withdrawal and demonstrated for the first time brain 
region-specific neuroadaptations of the oxytocin system, which may contribute to abstinence-induced 
negative emotional state. 
 
Introduction 
Cocaine addiction is a chronic relapsing disorder characterized by negative emotional symptoms 
during long-term abstinence. Former cocaine addicts experience emotional impairment, which can 
trigger relapse to drug use, and there is currently no effective pharmacotherapy for the treatment of 
cocaine addiction (Soyka & Mutschler, 2016). 
While the acute and chronic consequences of cocaine use have been broadly investigated, the 
mechanisms underlying abstinence-induced emotional impairment remain to be elucidated. There is 
evidence to suggest that the oxytocin (OT) system, which is implicated in emotional regulation due to 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
its anxiolytic, prosocial and antidepressant properties (see Neumann & Landgraf, 2012; Neumann & 
Slattery, 2016) may have a role in cocaine addiction/withdrawal. Indeed, central and peripheral OT 
administration decreases cocaine-induced hyper-locomotion, stereotypies and self-administration in 
rodents (see Sarnyai & Kovacs, 1994; McGregor & Bowen, 2012; Zhou et al., 2015). Moreover, i.c.v. 
administration of OT attenuates cue-induced reinstatement of cocaine-seeking (Morales-Rivera et al., 
2014). Chronic cocaine administration decreases plasma OT levels and OT immunoreactivity within 
the hypothalamus and hippocampus (Sarnyai et al., 1992; Johns et al., 1997). Moreover, increased 
OTR binding was observed in the amygdala following cocaine reinstatement in mice (Georgiou et al., 
2015a). With regards to OT’s role during drug withdrawal, we have previously demonstrated a 
dysregulation of the OT system following opioid abstinence and that the oxytocin analogue carbetocin 
prevents opioid abstinence-induced emotional impairment in mice, suggesting a key role of this 
system in emotional regulation during abstinence (Zanos et al., 2014a); however the role of oxytocin 
during cocaine abstinence remains unclear. 
Here, we behaviourally characterized a mouse model of prolonged cocaine abstinence and assessed its 
effect on the OTR system. We also examined the effect of chronic cocaine administration and 
withdrawal on the hypothalamic-pituitary-adrenal (HPA) axis activity, since cocaine-abuser pregnant 
women showed lower plasma OT levels and a concomitant blunted cortisol response (Light et al., 
2004). Our findings clearly demonstrate the emergence of an emotional impairment during prolonged 
cocaine abstinence and brain region-specific neuroadaptations of the oxytocin system, which may 
contribute to these affective behaviors. Given the impact of the abstinence-induced negative 
emotional state towards triggering relapse and the lack of effective pharmacotherapies, our model 
may assist in the development of novel drug targets for the treatment of cocaine addiction. 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Material and Methods 
Animals 
Male, 7-week old, C57BL/6J mice (Charles River, UK), were singly-housed in a temperature-
controlled environment with a 12:12 hour light/dark cycle and access to food/water ad libitum.  
Ethical standards: All experimental procedures were approved by the U.K. Animal Scientific 
Procedures Act (1986). 
 
Chronic escalating-dose cocaine administration paradigm 
Mice were randomly divided into four treatment groups: chronic saline or cocaine and saline or 
cocaine withdrawal. Mice were injected (i.p.) with saline (4ml/kg) or escalating-dose cocaine (Fig. 
1A; Sigma-Aldrich, Poole, UK), as previously described (Bailey et al., 2008). Cocaine-treated mice 
received 3 cocaine injections 1-hour apart (3x15 mg/kg/day on days 1-4, 3x20 mg/kg/day on days 5-8, 
3x25 mg/kg/day on days 9-12, and 3x30 mg/kg/day on days 13 and 14; Fig. 1A). Body weights were 
measured daily before the injections and 1, 6, 12 and 14 days following the last treatment injection. 
For biochemical measurements, animals were euthanized by a 30-sec exposure to CO2 followed by 
decapitation 1 hour (chronic group) and 14 days (withdrawal group) after their last treatment 
injection. Brains were stored at -80oC until use.  
 
Experiment 1: Behavioral characterization 
Following cocaine withdrawal, mice were assessed for sociability, memory, anxiety, motor 
coordination, anhedonia and depressive-like behaviors (timeline: Figure 1A). 
Three-chambered social approach test (3-CB) 
The 3-CB test was used to assess for sociability behaviors and was carried out as previously described 
(Zanos et al., 2014a). Briefly, the test mouse was placed into the middle chamber of an interconnected 
three-chambered box. During the habituation phase, the test animal had free access to all the chambers 
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for 10 min. Then, two small cages were placed in each of the end-chambers and an unfamiliar male 
C57BL/6J mouse (same age as the test mouse) was placed into one of these smaller cages (social 
chamber), while the other cage remained empty (empty chamber). Then, the test mouse was allowed 
to explore the apparatus for another 10 min. Time spent in each chamber of the 3-CB apparatus was 
automatically measured by an automated tracking system (EthoVision v.3.0, Noldus Information 
Technology, Netherlands). Sociability behaviour was determined by calculating the time each animal 
spent in the social vs empty chamber. 
 
Novel object recognition (NOR) 
Mice were assessed for short-term recognition memory in the NOR test, as previously described 
(Georgiou et al., 2016). Briefly, mice were habituated to the NOR arena (30x20x20cm) for 20 
minutes. During the acquisition phase two identical objects (either dice or marble attached on a clear 
plastic square block with dimensions 4.5x4.5x4.0cm) were placed in the arena and mice allowed to 
explore both objects for 20 minutes. Then, mice were returned to their home cages for a retention time 
of 35 minutes. During the testing phase one of the “familiar” objects was replaced by a novel object 
and the mouse was re-introduced into the NOR arena and allowed to explore for 2 minutes. Objects 
were placed in the same spatial location every time and the object chosen to be the novel object was 
counterbalanced. The sessions were recorded using a video-camera and the time spent interacting with 
each object (when the mouse’s nose was in contact with the object or directed at the object within ≤2 
cm) was scored by an observer blind to the treatment groups. 
 
Light/Dark box 
Anxiety-like behaviors were assessed using the Light/Dark box (L/D box), as previously described 
(Crawley et al., 1997). Briefly, mice were placed in the illuminated compartment of the L/D box 
(40x20x20cm) and allowed to explore for 5 minutes. The sessions were recorded using a video-
camera and the time spent in the illuminated and dark compartment was scored. Anxiety-like 
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behaviour was determined by calculating the amount of time spent in the illuminated vs the dark 
compartment.  
 
Rota-rod 
Motor coordination was assessed using the accelerated rota-rod (Ugo Basile, Milan, Italy) paradigm, 
which consisted of 3 trials (60-120 sec inter-trial interval) during the same day. The rotarod was set to 
accelerate at a rate of 20 rpm with a staring speed of 4rpm. The latency to fall was scored live during 
the experimental session by an observer blind to treatment groups. The average latency for the three 
trials was calculated. 
 
Sucrose preference - anhedonia 
The sucrose preference test was carried out as previously described (Zanos et al., 2016). Briefly, on 
day 1, two bottles containing tap water were introduced on the two opposite sides of the home-cages. 
On day 2, water consumption from each bottle was measured and another bottle containing 1% 
sucrose solution was placed at the least preferred side for another 24 hours. Sucrose preference was 
calculated as [sucrose consumption/(total liquid consumption) x100] for the assessment of anhedonia. 
 
Forced-swim test (FST) 
The FST was carried out as previously described (Zanos et al., 2015b). Briefly, mice were 
individually placed into clear glass cylinders (25cm height x 17cm diameter) filled with 2.5 litres of 
water at room temperature (24±1oC) for 6 minutes. The test session was recorded using a digital 
video-camera (Sony Handycam CX-250, Sony, Japan). Immobility time, defined as passive floating 
with no additional activity other than that needed to keep the mouse head above water, was scored by 
an observer blind to the treatment groups for the last 4 minutes of the 6-min test.  
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Experiment 2:  Locomotion/Biochemical alterations 
Locomotor activity 
Locomotor activity was measured daily during the chronic administration paradigm described above, 
as well as 14 days following drug cessation in locomotor chambers (40cm x 20cm x 20cm; Linton 
Instrumentation, U.K.), according with Wright et al., (2016). During the administration period, mice 
were habituated daily in locomotor chambers for 60 minutes prior to saline/cocaine injections in order 
to assess basal activity. Then, mice received an i.p. injection of saline or cocaine (escalating dose as 
described above) and were returned immediately to the locomotor chambers. Mice received 3 daily 
injections (saline or cocaine) at 1-hour interval and horizontal and vertical (i.e., rearing) activities 
were measured after each injection (3hrs in total). Horizontal and vertical activities were recorded as 
the number of sequential infrared beam breaks every 5 mins. The average activity, during both basal 
and stimulated activities, was calculated.  
 
Stereotypy scoring  
All mice were scored for stereotypy behaviour 30 min after each daily injection for a period of 30 
seconds. The rating was based on a slight modification of the scale used elsewhere (Bailey et al., 
2007; Metaxas et al., 2012) and consists of a graded scale of behaviours; 1: asleep, inactive; 2: alert, 
actively grooming; 3: increased sniffing; 4: intermittent rearing and sniffing; 5: increased locomotion; 
6: intense sniffing in one location; 7: continuous pivoting and sniffing/hyperlocomotion; 8: 
intermittent rearing and sniffing with locomotion; 9: maintained rearing and sniffing; 10: splayed 
limbs. Stereotypy behaviour of each mouse was recorded during the saline/cocaine administration 
period (i.e., days 1-14), as well as following 14 days of withdrawal (i.e., day 28). The median 
stereotypy score of the three injections on each day was calculated for each treatment group. Scoring 
was performed during locomotor testing by two experimenters blind to the treatment groups. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
OTR autoradiography 
OTR autoradiography in brains of chronically-treated and 14–day withdrawn mice was carried out as 
previously described (Zanos et al., 2014b; Zanos et al., 2015a). For the determination of total binding, 
slides were incubated in 50pM [125I]-ornithine vasotocin (OVTA) (PerkinElmer, 81.4 TBq/mmol) for 
60 minutes. For the determination of NSB, adjacent sections were incubated with [125I]-OVTA 
(50pM) in the presence of 50μM unlabelled (Thr4, Gly7)-oxytocin (Bachem, Germany).   
 
Plasma corticosterone levels 
Trunk blood was collected in EDTA-containing tubes and spun at 2000xg at 4oC for 15 minutes. 
Plasma corticosterone measurements were performed as previously described (Georgiou et al., 
2015b). 
 
Statistical Analysis 
All the values are expressed as the mean ± SEM. All statistical analyses were performed using 
GraphPad v6 (GraphPad software Inc., La Jolla, CA, USA). For the analysis of locomotor activity, 
stereotypy scores and body weights, two-way repeated measures ANOVA was performed with 
factors, “treatment” and “day (repeated factor)”. Since the expression of behavioural stereotypy was 
measured with a behavioural rating scale, non-parametric Mann Whitney U-test was used on 
individual test days as a supplementary analysis to confirm ANOVA results. Two-way repeated 
measures ANOVA was performed for the 3-CB with factors “treatment” and “side (repeated factor)”. 
For the NOR test, one-sample t-test was performed and the reference value was set at 0.5 
discrimination ratio. Student’s unpaired t-test was performed for the light/dark box, rotarod, FST and 
sucrose preference test. Differences in OTR binding were assessed with a two-way ANOVA with 
factors “brain region” and “treatment”. Plasma corticosterone levels were analysed by a two-way 
ANOVA with factors “treatment” and “withdrawal”. ANOVAs were followed by Holm-Sidak post-
hoc comparison when significance was reached (p<0.05). 
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Results 
Effect of cocaine withdrawal on sociability, memory, anxiety-like, motor coordination, 
anhedonia and depressive-like behaviors. 
Three-chambered social approach test. Both saline- and cocaine-withdrawn animals spent more time 
in the social chamber compared to the empty cage (‘side’ F[1,8]=10.47, p<0.05; ‘treatment’ 
F[1,8]=1.599, p>0.05; ‘side’x‘treatment’ F[1,8]=1.431, p>0.05; Figure 1B) 
Novel object recognition. Saline-withdrawn animals manifested normal object recognition memory 
(p<0.05), whereas cocaine-withdrawn animals showed object recognition memory impairment 
(p>0.05; Figure 1C). 
Light/Dark Box. Cocaine-withdrawn animals spent less time in the illuminated area showing higher 
anxiety-like behavior compared to saline-withdrawn animals (p<0.05; Figure 1D). 
Rota-rod. There was no difference between saline- and cocaine-withdrawn animals in the latency to 
fall from the rotating rod (p>0.05; Figure 1E). 
Sucrose-preference. Cocaine-withdrawn mice had decreased sucrose preference compared to controls, 
indicative of anhedonic phenotype (p<0.05; Figure 1F). 
Forced-swim test. There was no statistically significant difference in immobility time of cocaine- and 
saline-withdrawn animals (p>0.05; Figure 1G). 
 
Effects of chronic cocaine administration and withdrawal on stimulated and basal horizontal 
and vertical activity  
Basal locomotor activity: A significant effect of ‘treatment’ (F[1,10]=8.677, p<0.05), ‘day’ 
(F[14,140]=23.68, p<0.001) and ‘treatment’ x ‘days’ interaction (F[14,140]=3.672, p<0.001) was also 
observed in basal horizontal activity. Cocaine-treated animals increased their basal horizontal activity 
on days 7, 9-14 during chronic administration, as well as following 14 days of withdrawal (day 28) 
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compared to controls (Figure 2B). A significant main effect of ‘treatment’ (F[1,10]=18.43; p<0.01) was 
observed in basal vertical activity (Figure 2C).  
Stimulated locomotor activity: A significant main effect of ‘treatment’ (F[1,10]=108.0, p<0.001), ‘day’ 
(F[13,130]=3.887, p<0.001) and ‘treatment’ x ‘days’ interaction (F[13,130]=6.915, p<0.001) was revealed 
following cocaine administration (Figure 2D). Cocaine-treated animals showed increased horizontal 
locomotor activity compared to controls (p<0.001). Following 3 days of cocaine administration, there 
was an increase in cocaine-stimulated horizontal activity compared to Day 1 (p<0.001), indicating the 
acquisition of behavioural sensitization. A significant main effect of ‘treatment’ (F[1,10]=13.45, 
p<0.01) was observed in stimulated vertical activity following chronic cocaine administration (Figure 
2E).  
 
Effects of chronic cocaine administration and withdrawal on stereotypy scores  
A significant effect of ‘treatment’ (F[1,10]=1751.0, p<0.001), ‘day’ (F[14,140]=10.00, p<0.001) and 
‘treatment’ x ‘days’ interaction (F[14,140]=13.16, p<0.001) was observed in stereotypy behavior. 
Cocaine-treated animals increased their stereotypy behavior throughout the cocaine administration 
paradigm (days 1-14; Figure 2F). Following 14 days of withdrawal (day 28), no significant difference 
in the stereotypy behaviors was observed in cocaine- vs saline-treated mice (Figure 2F). 
 
Effects of chronic cocaine administration and withdrawal on body weight 
A significant effect of ‘treatment’ (F[1,10]=19.06, p<0.01), ‘day’ (F[17,170]=2.854, p<0.001) and 
‘treatment’ x ‘days’ interaction (F[17,170]=3.372, p<0.001)  was observed on body weights. Body 
weight of cocaine-treated animals was decreased reaching significance on day 4 compared to saline-
treated mice (Figure 2G). This decrease was persistent throughout the administration paradigm and up 
to day 22 (8-days withdrawal). Following 12- and 14-days withdrawal from cocaine, no statistically 
significant difference was observed in the body weights compared to controls (Figure 2G). 
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Effects of chronic cocaine administration and 14-day withdrawal on the oxytocinergic system. 
Two-way ANOVA did not reveal significant ‘brain region’, ‘treatment’ (olfactory nuclei: 
F[3,53]=0.3721; p>0.05; striatum: F[3,48]=2.785; p>0.05), or an interaction (olfactory nuclei: 
F[6,53]=0.5148; p>0.05; striatum: F[6,48]=0.639; p>0.05) effect  in the olfactory nuclei or the striatum of 
chronically cocaine-treated and -withdrawn mice (Figure 3A,B). A significant effect of ‘brain region’ 
(F[1,36]=365.5; p<0.001) and ‘brain region’ x ‘treatment’ interaction (F[3,36]=3.869; p<0.05) was 
observed in the cortical regions analyzed. Post-hoc analysis showed a significant increase in OTR 
binding in the piriform cortex following cocaine administration and withdrawal (Figure 3A,C). A 
significant ‘treatment’ (F[3,52]=16.94; p<0.001) effect and a close to significance ‘brain region’ x 
‘treatment’ interaction (F[6,52]=2.118; p=0.06) was observed in the septum. Post-hoc analysis revealed 
a significant increase in OTR binding following the 14-day withdrawal in the medial septum (MS) 
and ventral limb of diagonal band (VDB) compared to control (Figure 3A,E) and chronic cocaine 
groups (Figure 3A,E). In the lateral septum (LS), OTR binding was increased following cocaine 
administration and withdrawal compared to controls (p<0.01; Figure 3A,E). In the forebrain, a 
significant effect of ‘brain region’ (F[2,54]=192.7; p<0.001), ‘treatment’ (F[3,54]=4.505; p<0.01) and an 
interaction (F[6,54]=2.640; p<0.05) was observed. Post-hoc analysis showed an increase in amygdalar 
OTR binding following cocaine administration and withdrawal compared to the respective controls 
(Figure 3A,F). 
 
Effects of chronic cocaine administration and 14-day withdrawal on plasma corticosterone 
levels 
Two-way ANOVA showed a significant main effect of chronic cocaine treatment (F[1,35]=15.88, 
p<0.001; Figure 3G) on plasma corticosterone levels. Corticosterone levels were persistently 
increased following cocaine treatment/withdrawal. 
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Discussion 
We demonstrated that chronic cocaine administration increases OTR binding in the piriform cortex, 
amygdala and LS; an increase that persists following withdrawal. A withdrawal-specific increase in 
OTR binding was observed in the MS and VDB. These receptor changes were accompanied by the 
emergence of an anxiogenic-like phenotype, anhedonia and memory impairment. Increased plasma 
corticosterone levels were also observed following chronic cocaine administration and abstinence.  
 
Although cocaine withdrawal did not induce social avoidance, motor incoordination or behavioral 
despair, we observed memory impairments, anxiety-like behavior and anhedonia. These findings are 
in line with clinical observations from abstaining cocaine addicts (Gawin & Kleber, 1986; 
Weddington et al., 1990; Morton, 1999; Kelley et al., 2005; Woicik et al., 2009; Leventhal et al., 
2010), supporting the translational value of our model. Moreover, we observed increased locomotor 
activity 14 days after drug cessation. Increased locomotor activity in the drug-paired environment has 
been linked with contextual sensitization, which has been associated with persistent molecular 
neuroadaptations that might contribute to drug craving following abstinence (see Robinson & 
Berridge, 2008). Drug craving is common among cocaine abstinent individuals, and it is often 
triggered by environmental cues previously associated with cocaine use (see Wolf, 2016), which 
further highlights the validity of our model. Interestingly, increased activity has been also associated 
with anxiety-like behaviours in mice (Lever et al., 2006), which is in line with the observed cocaine 
withdrawal-induced anxiogenic phenotype. 
 
We then assessed the effect of chronic cocaine administration and withdrawal on the oxytocinergic 
system in order to identify possible mechanisms underlying the observed emotional impairment. We 
found a persistent cocaine-induced upregulation of OTR in the amygdala and LS, and a specific 
withdrawal-induced upregulation in the MS and VDB. Considering the role of the amygdala and 
septum in the antidepressant/anxiolytic actions of OT (Curley et al., 2012; Zanos et al., 2014a), the 
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upregulation of the OTR binding in these regions may represent a neuroadaptive response of the 
oxytocinergic system to counteract the negative consequences of cocaine administration/withdrawal. 
Indeed, OT administration has been shown to reduce anhedonia in schizophrenic patients (see Rich & 
Caldwell, 2015) and induce a hedonic state in rodents (see Slattery & Neumann, 2010). Therefore, 
dysregulation of the OTR system might contribute to the development of anhedonia observed in the 
present study.  
 
Oxytocin administration has also been shown to decrease anxiety-like behaviors in rodents (see 
Neumann & Slattery, 2016), and humans (Guastella et al., 2009) and to decrease amygdala reactivity 
to fear in patients with geneneralized social anxiety disorder (Labuschagne et al., 2010). Notably, 
amygdala is one of the brain regions where we have observed an increase in OTR binding following 
cocaine administration/withdrawal, suggesting that this dysregulation may underlie the development 
of anxiety-like behaviors during withdrawal. In agreement, a similar dysregulation of the OTR system 
was previously observed in the amygdala following chronic morphine administration/withdrawal, 
which was associated with an anxiogenic phenotype (Zanos et al., 2014a). Although in the present 
study we have not assessed whether emotional regulation occurs during chronic cocaine 
administration, the fact that the OTR dysregulation in the LS and amygdala occurred both following 
cocaine administration and withdrawal suggests that behavioral deficits would have been also present 
during chronic cocaine exposure. Indeed, earlier studies have identified emotional deficits during 
chronic cocaine exposure in both animals (Morales-Rivera et al., 2014) and humans (Morton, 1999; 
Zubaran et al., 2013). 
 
A plausible mechanism underlying these neuroadaptations in the OTR system is that there might be a 
compensatory mechanism to counteract a hypo-oxytocinergic state caused by chronic cocaine 
administration/withdrawal. Indeed, Sarnyai et al., (1992) reported decreased hypothalamic OT content 
and reduced plasma OT levels in rats chronically-treated with cocaine. In addition, Baracz et al., 
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(2016) found decreased plasma OT levels following methamphetamine self-administration/extinction. 
Taken together, it can be postulated that cocaine withdrawal induces a hypo-oxytocinergic tone and a 
subsequent neuroadaptation of the OTR system to counteract the negative behavioural consequences 
of abstinence. Therefore, it would be of great interest for future studies to investigate the effect of 
oxytocin administration in preventing cocaine withdrawal-induced behavioral impairments. However, 
it is important to mention that OT also binds and activates vasopressin receptors (Busnelli et al., 
2013), which might induce anxiogenic and pro-stress effects (see Neumann & Landgraf, 2012). 
Therefore, studies assessing the effects of exogenous administration of OT should be cautious on the 
dosing regimen. 
 
We have also observed increased corticosterone levels following cocaine administration, which 
persisted following withdrawal, suggesting that the cocaine effect on HPA axis activity does not 
normalize even after prolonged abstinence. Elevated cortisol secretion is evident in abstinent cocaine 
abusers, lasting for at least 3 weeks following cessation of cocaine-taking (Contoreggi et al., 2003), 
further supporting the translational validity of our model. In line with our findings, it has been 
previously demonstrated that cocaine-treated rats, have increased plasma corticosterone levels 
following a 14-day withdrawal (Zhou et al., 2011). The persistent cocaine-induced hypersensitivity of 
the HPA axis may be the cause or consequence of the observed alterations on the oxytocinergic 
system. Indeed, there is evidence supporting both these hypotheses. One of the mechanisms 
underlying the anti-stress effect of oxytocin involves the inhibition of hypothalamic CRF release 
(Neumann et al., 2000). In addition, a 5-day oxytocin administration decreased plasma corticosterone 
levels in rats (Petersson et al., 1999). Moreover, dexamethasone administration increased OTR 
binding in the septum and amygdala of rats (Patchev et al., 1993). Therefore, it is possible that 
alterations of the oxytocinergic system may lead to a dysregulated HPA axis activity and 
consequently to the emotional impairment, or a persistent dysregulation of the HPA axis to have 
caused the changes observed in the oxytocinergic system. These hypotheses require further 
investigation. 
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In conclusion, we have demonstrated profound alterations in the oxytocinergic system following 
chronic cocaine administration and withdrawal in brain regions associated with the observed 
behavioural impairment, confirming a key role of the OT system during cocaine drug withdrawal. 
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Figure Legends 
Figure 1. Behavioral effects of cocaine withdrawal.  Figure 1. Behavioral effects of cocaine 
withdrawal.  (A) Experimental timeline. While cocaine withdrawal did not induce (B) sociability 
deficits it induced (C) short-term objectect recognition impairment and (D) an anxiogenic phenotype 
in the light/dark box task. (E) Cocaine-withdrawan mice did not show motor-coordination deficits in 
the rota-rod test. In addition, cocaine withdrawal (F) decreased sucrose preference compared to 
saline-witdrawan mice, whereas it did not significantly affect (G) immobility time in the forced-swim 
test. Data are expressed as mean ± SEM (n=5-6/group); *p<0.05. Abbreviations: 3-CB, three-
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chambered social approach test; COC, cocaine; FST, forced-swim test; Inj, injection; L/D, light/dark 
box; NOR, novel-object recognition; RR, rotarod; SAL, saline; sec, seconds; Sucr. Pref., sucrose 
preference. 
 
Figure 2. Effects of cocaine administration and withdrawal on locomotor activity, stereotypy and 
body weight. (A) Experimental timeline. Chronic cocaine administration and 14-day withdrawal 
increased basal (non-stimulated) (B) horizontal and, (C) vertical activity. Chronic cocaine 
administration increased stimulated (D) horizontal and, (E) vertical activity. (F) Chronic cocaine 
administration increased stereotypy behaviors. (G) Cocaine treatment decreased the body weight of 
mice during administration and following 8 days of withdrawal. No difference in body weight was 
observed following 12 and 14 days withdrawal. Data are expressed as mean ± SEM (n=6/group); 
*p<0.05, **p<0.01, ***p<0.001 vs saline, ###p<0.001 vs cocaine Day 1. Abbreviations: COC, 
cocaine; CORT, corticosterone; Inj, injection; OTR, oxytocin receptor; SAL, saline. 
 
Figure 3. Effects of chronic cocaine administration and withdrawal on brain oxytocin receptor 
binding and plasma corticosterone levels. A) Representative OTR autoradiograms of adjacent 
coronal brain sections at the level of the olfactory nuclei (Bregma 2.46mm, first row), cortex/striatum 
(Bregma 0.86mm, second row), septum (Bregma 0.14mm, third row) and the forebrain (Bregma -
2.06mm, second row). The color bar illustrates a pseudo-color interpretation of black and white film 
images in fmol/mg tissue equivalent. Quantitative oxytocin receptor autoradiographic binding in (B) 
olfactory nuclei (n=5-6/group), (C) cortex (n=6/group), (D) (n=4-6/group) striatum, (E) septum (n=4-
6/group) and (F) forebrain (n=6/group) of mice treated with cocaine or underwent cocaine 
withdrawal. (G) Chronic cocaine administration and 14-day withdrawal increased plasma 
corticosterone levels (n=6-12/group). Data are expressed as mean ± SEM; *p<0.05, **p<0.01, 
***p<0.001 vs saline or saline withdrawal. Abbreviations: Acb, nucleus accumbens; Amy, 
amygdala; AOL, anterior olfactory nucleus-lateral; AOM, anterior olfactory nucleus-medial; 
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AOV, anterior olfactory nucleus-ventral; CgCx, cingulate cortex; COC, cocaine; CORT, 
corticosterone; CPu, caudate putamen; Hip, hippocampus; LS, lateral septum; MS, medial 
septum; NSB, non-specific binding; OTR, oxytocin receptor; SAL, saline; Th, thalamus; Tu, 
olfactory tubercle; VDB, vertical limb of diagonal band of Broca. 
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